Cui-Yun Liu

5.2k citations
46 papers · 4.1k indexed · 3 hit papers · h-index 24
Topics
MicroRNA in disease regulation (17 papers)Cancer-related molecular mechanisms research (10 papers)RNA modifications and cancer (9 papers)

In The Last Decade

Cui-Yun Liu

43 papers receiving 4.0k citations

Hit Papers

A circular RNA protects the heart from pathological hyper...2014202620182022201620142015200400600

Peers

Cui-Yun Liu
Comparison fields: 5 of 112
  • Molecular Biology 3.4k
  • Cancer Research 2.9k
  • Cardiology and Cardiovascular Medicine 429
  • Epidemiology 428
  • Surgery 245
Replace Regalla Kumarswamy with:
Regalla Kumarswamy Germany
William W. Du Canada
Ingeborg van der Made Netherlands
Carmen C. Sucharov United States
Yun Zhong China
Jian Zhao China
Yiping Wu China
Cui-Yun Liu relative to Regalla Kumarswamy Germany Regalla Kumarswamy's profile →
Citations per field
00.5×3.3×
Regalla Kumarswamy · 1×
Citations per year

Countries citing papers authored by Cui-Yun Liu

Since Specialization
Citations

This map shows the geographic impact of Cui-Yun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui-Yun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui-Yun Liu more than expected).

Fields of papers citing papers by Cui-Yun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cui-Yun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui-Yun Liu. The network helps show where Cui-Yun Liu may publish in the future.

Co-authorship network of co-authors of Cui-Yun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Cui-Yun Liu. A scholar is included among the top collaborators of Cui-Yun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui-Yun Liu. Cui-Yun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 9
6 10
7 8
8 4
9 22
10 40
11 63
12 38
13 213
14 8
15 88
16 49
17 58
18 394
19 89
20 99

About Cui-Yun Liu

Cui-Yun Liu is a scholar working on Cancer Research, Molecular Biology and Biochemistry, having authored 46 papers that have together received 4.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Cancer Research (2.9k citations), Molecular Biology (3.4k citations) and Cardiology and Cardiovascular Medicine (429 citations). Cui-Yun Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lu‐Yu Zhou, Peifeng Li, Kun Wang, Fang Liu, Bo Long, Teng Sun, Man Wang, Yanhan Dong, Jianxun Wang and Murugavel Ponnusamy. Their work appears in journals such as Circulation, Nature Communications and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026